Cargando…
MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1
PURPOSE: The prognosis of pancreatic cancer ranks among the worst of all cancer types, which is primarily due to the fact that during the past decades little progress has been made in its diagnosis and treatment. Here, we set out to investigate the role of microRNA 138 (miR-138-5p) in the regulation...
Autores principales: | Yu, Chao, Wang, Min, Li, Zhipeng, Xiao, Jie, Peng, Feng, Guo, Xingjun, Deng, Yazhu, Jiang, Jianxin, Sun, Chengyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445488/ https://www.ncbi.nlm.nih.gov/pubmed/25875420 http://dx.doi.org/10.1007/s13402-014-0200-x |
Ejemplares similares
-
miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1
por: Tian, She, et al.
Publicado: (2016) -
Silencing of microRNA-138-5p promotes IL-1β-induced cartilage degradation in human chondrocytes by targeting FOXC1: miR-138 promotes cartilage degradation
por: Yuan, Y., et al.
Publicado: (2016) -
MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12
por: He, Zhiwei, et al.
Publicado: (2019) -
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
por: Huang, Hui, et al.
Publicado: (2020) -
miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
por: Zhang, Dapeng, et al.
Publicado: (2020)